upjohn attribut increas cost-control
measur sale growth sever major product
world-wid sale upjohn health care product rose 15 %
fourth quarter 14 % year howev halcion
sale fell 1 % last year 23 % fourth quarter
critic sleep medic claim user experi
higher incid advers reaction user
drug class
separ group upjohn sharehold yesterday
charg compani top execut fraudul
conceal inform halcion demand special
meet elect new offic director
complaint file u.s. district court new york
seek repres upjohn sharehold class action
spokesman upjohn said compani seen
lawsuit comment ad confid
commit fraud
